IP Library Granted Patent US 9,707,409
Granted Patent B2
US 9,707,409 · App. 13/696,858 · Granted Jul 18, 2017

Efficient circadian and related system modulation with a sleep mask

Inventor: Michael Edward Colbaugh (Level Green, PA)
Assignee: Koninklijke Philips N.V.
A61N5/0618A61N2005/0628A61N2005/0648A61N2005/0652A61N2005/0662
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,707,409
App. No.
13/696,858
Filed
Nov 8, 2012
Granted
Jul 18, 2017
Kind
B2
Art Unit
3769
USPC
607/88
Abstract

Light therapy is provided to a subject through a sleep mask. The sleep mask is configured to deliver electromagnetic radiation to the closed eyelids of the subject within a defined optimal wavelength band that is therapeutically impactful in modulating circadian and related systems of the subject.

Claims (26)

1. A sleep mask configured to provide light therapy to a subject, the sleep mask comprising:

a shield configured to cover the eyes of a subject wearing the sleep mask such that the shield provides a barrier between ambient radiation and the eyes of the subject;

a radiation source carried by the shield, the radiation source being configured to emit radiation onto a closed eyelid of the subject if the subject is wearing the sleep mask, wherein the radiation emitted by the radiation source is within a wavelength band between 490 nm and 520 nm; and

a controller configured to:

control emission of radiation by the radiation source to facilitate estimation of eyelid attenuation for the closed eyelid of the subject by the controller;

estimate eyelid attenuation for the closed eyelid of the subject; and

control emission of radiation by the radiation source based on the estimation of eyelid attenuation for the closed eyelid of the subject according to a light therapy plan that specifies an irradiance within the wavelength band that impacts a sleep cycle of the subject such that the radiation emitted by the radiation source within the wavelength band will have the irradiance specified by the light therapy plan after the radiation has been attenuated by the eyelid of the subject.

2. The sleep mask of claim 1 , wherein the light therapy plan dictates continuous emission of the radiation by the radiation source at a fixed intensity.

3. The sleep mask of claim 1 , wherein the light therapy plan dictates emission of the radiation by the radiation source in pulses.

4. The sleep mask of claim 1 , wherein the wavelength band is between 500 nm and 510 nm.

5. A method of providing light therapy to a subject, the method comprising:

emitting electromagnetic radiation onto a closed eyelid of the subject, wherein the emitted radiation is within a wavelength band between 490 nm and 520 nm;

controlling emission of the electromagnetic radiation to facilitate estimation of eyelid attenuation for the closed eyelid of the subject;

estimating eyelid attenuation for the closed eyelid of the subject; and

controlling emission of the electromagnetic radiation based on the estimation of eyelid attenuation for the closed eyelid of the subject according to a light therapy plan that specifies an irradiance within the wavelength band that impacts a sleep cycle of the subject such that the emitted radiation within the wavelength band will have the irradiance specified by the light therapy plan after the radiation has been attenuated by the eyelid of the subject.

6. The method of claim 5 , wherein the light therapy plan dictates continuous emission of the radiation at a fixed intensity.

7. The method of claim 5 , wherein the light therapy plan dictates emission of the radiation in pulses.

8. The method of claim 5 , wherein the wavelength band is between 500 nm and 510 nm.

9. A system configured to provide light therapy to a subject, the system comprising:

means for emitting electromagnetic radiation onto a closed eyelid of the subject, wherein the emitted radiation is within a wavelength band between 490 nm and 520 nm;

means for controlling emission of the electromagnetic radiation to facilitate estimation of eyelid attenuation for the closed eyelid of the subject;

means for estimating eyelid attenuation for the closed eyelid of the subject; and

means for controlling emission of the electromagnetic radiation based on the estimation of eyelid attenuation for the closed eyelid of the subject according to a light therapy plan that specifies an irradiance within the wavelength band that impacts a sleep cycle of the subject such that the emitted radiation within the wavelength band will have the irradiance specified by the light therapy plan after the radiation has been attenuated by the eyelid of the subject.

10. The system of claim 9 , wherein the light therapy plan dictates continuous emission of the radiation by the means for emitting electromagnetic radiation at a fixed intensity.

11. The system of claim 9 , wherein the light therapy plan dictates emission of the radiation by the means for emitting electromagnetic radiation in pulses.

12. The system of claim 9 , wherein the wavelength band is between 500 nm and 510 nm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2012
From: COLBAUGH, MICHAEL EDWARD
To: KONINKLIJKE PHILIPS ELECTRONICS N V
Reel/Frame 029263/0558 →
Continuity (2)
Provisional Application 61334616 · May 14, 2010
Related Publication 20130060306A1 · Mar 7, 2013